CINECA IRIS Institutional Research Information System

Sfoglia per Rivista  HEMATOLOGY JOURNAL

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 13 di 13
Titolo Data di pubblicazione Autore(i) File
Anemia and iron overload due to genetic defects of iron recycling, aceruloplasminemia and hemochromatosis type 4 2002 M. De Gobbi; A. Roetto; S. Bosio; F. Daraio; F. Alberti; M.R. Barilaro; F. Longo; U. Bonuccelli; C. Camaschella
Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression. 2000 LANDOLFO S; GUARINI A; RIERA L; GARIGLIO M; GRIBAUDO G; CIGNETTI A; CORDONE I; MONTEFUSCO E; MANDELLI F; FOA R.
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 2001 MANCINI M; NANNI M; SIRLETO P; DE CUIA MR; CASTOLDI GL; D. CILLONI; CIMINO; G; MECUCCI C; PANE F; ANNINO L; DI RAIMONDO F; SANTORO A; SPECCHIA G; TEDESCHI; A; TODESCHINI G; FOA R
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma 2004 Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma. 2004 Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M.
Hereditary haemochromatosis 2002 Camaschella C; De Gobbi M; Roetto A
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors. 2002 BONATI A.; LUNGHI P.; GAMMAITONI L.; PINELLI S.; RIDOLO E.; DALL'AGLIO P.P.; V. PIACIBELLO; AGLIETTA M.
Myeloma management guidelines: a coMyeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. 2003 DURIE BG ;KYLE RA ;BELCH A ;BENSINGER W ;BLADE J ;BOCCADORO M ;CHILD JA ;COMENZO R ;DJULBEGOVIC B ;FANTL D ;GAHRTON G ;HAROUSSEAU JL ;HUNGRIA V ;JOSHUA D ;LUDWIG H ;MEHTA J ;MORALES AR ;MORGAN G ;NOUEL A ;OKEN M ;POWLES R ;ROODMAN D ;SAN MIGUEL J ;SHIMIZU
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation 2003 DURIE BG; KYLE RA; BELCH A; BENSINGER W; BLADE J; BOCCADORO M; CHILD JA; COMENZO R; DJULBEGOVIC B; FANTL D; GAHRTON G; HAROUSSEAU JL; HUNGRIA V; JOSHUA D; LUDWIG H; MEHTA J; MORALES AR; MORGAN G; NOUEL A; OKEN M; POWLES R; ROODMAN D; SAN MIGUEL J; SHIMIZU K; SINGHAL S; SIROHI B; SONNEVELD P; TRICOT G; VAN NESS B; SCIENTIFIC ADVISORS OF THE INTERNATIONAL MYELOMA FOUNDATION.
Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus 2001 Revoltella RP; Laricchia Robbio L; Moscato S; Vinante F; Fasciani A; Liberati AM; Reato G; Foa R
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters. 2002 M De Gobbi; F Daraio; A Roetto; F Alberti; S. Bosio; MR Barilaro; C Camaschella
Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma 2004 Falco P; Bertola A; Bringhen S; Cavallo F; Boccadoro M; Palumbo A
The natural history of hemochromatosis type 2. 2001 De Gobbi M; Roetto A; Piperno A; Papanikolau G; Loukopoulos D; Lockitch G; Girelli P; Gasparini P; Cox T; Cazzola M; Camaschella C
Mostrati risultati da 1 a 13 di 13
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile